These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10817522)

  • 1. Angiogenesis inhibitors. New anticancer strategy.
    Zgodziński W; Wallner G; Dabrowski A
    Pol J Pharmacol; 1999; 51(6):455-62. PubMed ID: 10817522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of angiogenesis in the treatment of tumors.
    Ostrowski K; Kinsner A
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):27-31. PubMed ID: 11266087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour vasculature as a target for anticancer therapy.
    Eatock MM; Schätzlein A; Kaye SB
    Cancer Treat Rev; 2000 Jun; 26(3):191-204. PubMed ID: 10814561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecules in anti-angiogenic therapy.
    Giavazzi R; Nicoletti MI
    Curr Opin Investig Drugs; 2002 Mar; 3(3):482-91. PubMed ID: 12054101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of angiogenesis inhibitors in tumour treatment.
    Fayette J; Soria JC; Armand JP
    Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis inhibitors in cancer therapy.
    Dredge K; Dalgleish AG; Marriott JB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):667-74. PubMed ID: 12901224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current strategies and future directions of antiangiogenic tumor therapy.
    Zhang ZL; Wang JH; Liu XY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):873-80. PubMed ID: 14515202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.
    Folkman J
    Exp Cell Res; 2006 Mar; 312(5):594-607. PubMed ID: 16376330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it].
    Klener P
    Klin Onkol; 2010; 23(1):14-20. PubMed ID: 20192069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and antiangiogenic therapy in hematologic malignancies.
    Dong X; Han ZC; Yang R
    Crit Rev Oncol Hematol; 2007 May; 62(2):105-18. PubMed ID: 17188504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
    Horsman MR; Siemann DW
    Cancer Res; 2006 Dec; 66(24):11520-39. PubMed ID: 17178843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
    Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
    Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [VEGF, anti-vEGF and diseases].
    Corvol P
    Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic cancer therapy.
    Cao Y
    Semin Cancer Biol; 2004 Apr; 14(2):139-45. PubMed ID: 15018898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic inhibitors: a new therapeutic strategy in oncology.
    Gasparini G; Longo R; Toi M; Ferrara N
    Nat Clin Pract Oncol; 2005 Nov; 2(11):562-77. PubMed ID: 16270097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.